Professional background
He advises healthcare companies on topics related to health regulations, litigation, research, drafting and negotiating of contracts.
Sébastien began his career in 1998 as a corporate lawyer for Roche and Schering-Plough, before practising within the "Healthcare Industry" department of Courtois Lebel from 2007. He then developed his own business before joining Fieldfisher Paris in 2016 as Of Counsel.
He speaks French and English.
Authored pieces
Life Sciences
Insight
The European Court of Justice opens the way for chemically synthesised generics of reference biological medicinal products
29.04.2026
In a landmark decision issued last Thursday, the Court of Justice of the European Union ruled that a medicines agency may grant a marketing authorisation for a chemically synthesised product as a generic of a reference biological medicinal product. This decision applies across all EU Member States and is expected to have significant implications for the pharmaceutical sector.
Life Sciences
Insight
French judges clarify the notion of medical devices
18.02.2025
The Paris Court of Appeal has just issued a landmark decision concerning the notion of medical devices, in the context of a five-year dispute between two French companies. Such decisions are rare, even in the other European countries which use the same EU legal definition for medical devices (e.g. Spain and United Kingdom - which has a similar definition despite the country is no longer being an EU member state).
Lawyers I've worked with
